MiSight 1 Day Contact Lenses

MiSight 1 day by CooperVision is the first soft contact lens FDA-approved specifically for slowing myopia progression in children.

FDA Approval

In November 2019, the FDA approved MiSight for:

• Slowing myopia progression in children 8-12
• Correcting myopia in children and adults
• Based on a 3-year clinical trial

How MiSight Works

The lens uses ActivControl® Technology:

• Central zone corrects myopia for clear vision
• Concentric treatment zones create peripheral defocus
• This defocus signal may slow eye growth

Clinical Evidence

**3-Year Study Results**:

• 59% slower myopia progression (controlled trial)
• 52% less axial elongation
• Maintained efficacy over 6 years in extension study

**Real-World Performance**:

• 40-50% average reduction in progression
• Results vary by individual

Who Can Wear MiSight?

FDA-approved criteria:

• Ages 8-12 at initiation
• Myopia: -0.25D to -4.00D
• Astigmatism: up to -0.75D
• Able to handle contact lenses

Daily Wear Routine

1. Wash hands thoroughly
2. Insert fresh lenses each morning
3. Wear for 10+ hours daily, 6+ days per week
4. Discard lenses at end of day
5. No cleaning or storage required

Advantages

• Daily disposable = excellent hygiene
• No overnight wear
• Familiar soft lens comfort
• FDA-approved indication